Luo et al. reported that IGF-1 therapy inhibits p53 nuclear translocation and nuclear p53-progerin interaction, which in turn relieves hepatocyte premature senescence and alleviates CCl4-induced hepatic fibrosis [87]. This evidence concerns the gene TP53 and Hepatic fibrosis.